Return to study ST000255 main page

Download data matrix(NIH WCMC Pilot & Feasibility Project: “Metabolomics of Neonatal Pulmonary Hypertension” in human ESI negative ion mode)

AnalysisSamplesFactorsUnits
ESI negative ion modeBP009Treatment:no PH (no pulmonary hypertension)% Area Ratio
ESI negative ion modeBP028Treatment:no PH (no pulmonary hypertension)% Area Ratio
ESI negative ion modeBP090Treatment:no PH (no pulmonary hypertension)% Area Ratio
ESI negative ion modeBP122Treatment:no PH (no pulmonary hypertension)% Area Ratio
ESI negative ion modeBP169Treatment:no PH (no pulmonary hypertension)% Area Ratio
ESI negative ion modeBP191Treatment:no PH (no pulmonary hypertension)% Area Ratio
ESI negative ion modeBP253Treatment:no PH (no pulmonary hypertension)% Area Ratio
ESI negative ion modeBP332Treatment:no PH (no pulmonary hypertension)% Area Ratio
ESI negative ion modeBP333Treatment:no PH (no pulmonary hypertension)% Area Ratio
ESI negative ion modeBP342Treatment:no PH (no pulmonary hypertension)% Area Ratio
ESI negative ion modeBP369Treatment:no PH (no pulmonary hypertension)% Area Ratio
ESI negative ion modeBP388Treatment:no PH (no pulmonary hypertension)% Area Ratio
ESI negative ion modeBP406Treatment:no PH (no pulmonary hypertension)% Area Ratio
ESI negative ion modeBP408Treatment:no PH (no pulmonary hypertension)% Area Ratio
ESI negative ion modeBP476Treatment:no PH (no pulmonary hypertension)% Area Ratio
ESI negative ion modeBP496Treatment:no PH (no pulmonary hypertension)% Area Ratio
ESI negative ion modeBP588Treatment:no PH (no pulmonary hypertension)% Area Ratio
ESI negative ion modeBP700Treatment:no PH (no pulmonary hypertension)% Area Ratio
ESI negative ion modeBP751Treatment:no PH (no pulmonary hypertension)% Area Ratio
ESI negative ion modeBP819Treatment:no PH (no pulmonary hypertension)% Area Ratio
ESI negative ion modeBP875Treatment:no PH (no pulmonary hypertension)% Area Ratio
ESI negative ion modeBP010Treatment:PH (pulmonary hypertension)% Area Ratio
ESI negative ion modeBP121Treatment:PH (pulmonary hypertension)% Area Ratio
ESI negative ion modeBP132Treatment:PH (pulmonary hypertension)% Area Ratio
ESI negative ion modeBP158Treatment:PH (pulmonary hypertension)% Area Ratio
ESI negative ion modeBP185Treatment:PH (pulmonary hypertension)% Area Ratio
ESI negative ion modeBP289Treatment:PH (pulmonary hypertension)% Area Ratio
ESI negative ion modeBP295Treatment:PH (pulmonary hypertension)% Area Ratio
ESI negative ion modeBP312Treatment:PH (pulmonary hypertension)% Area Ratio
ESI negative ion modeBP385Treatment:PH (pulmonary hypertension)% Area Ratio
ESI negative ion modeBP407Treatment:PH (pulmonary hypertension)% Area Ratio
ESI negative ion modeBP497Treatment:PH (pulmonary hypertension)% Area Ratio
ESI negative ion modeBP515Treatment:PH (pulmonary hypertension)% Area Ratio
ESI negative ion modeBP516Treatment:PH (pulmonary hypertension)% Area Ratio
ESI negative ion modeBP522Treatment:PH (pulmonary hypertension)% Area Ratio
ESI negative ion modeBP541Treatment:PH (pulmonary hypertension)% Area Ratio
ESI negative ion modeBP732Treatment:PH (pulmonary hypertension)% Area Ratio
ESI negative ion modeBP832Treatment:PH (pulmonary hypertension)% Area Ratio
ESI negative ion modeP003Treatment:PH (pulmonary hypertension)% Area Ratio
ESI negative ion modeP288Treatment:PH (pulmonary hypertension)% Area Ratio
ESI negative ion modeP295Treatment:PH (pulmonary hypertension)% Area Ratio
ESI negative ion modeP302Treatment:PH (pulmonary hypertension)% Area Ratio
  logo